Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Union Budget
Budget 2011-2012 Home
Industry Expectations - Budget 2011-2012
Industry Reactions - Budget 2011-2012
Budget 2010-2011
Budget 2010-2011 Home
Industry Expectations - Budget 2010-2011
Industry Reactions - Budget 2010-2011
Contributor's Corner
Bonanza Portfolio
Hemant K Gupta
Krish Bhatt
S A A R T H I
Trinity Investments
Exchange Information
BSE 2009 Holidays
NSE 2009 Holidays
Investor Guide
Depository & Dematerialisation
Grievance Redressal
Investor Guide
SEBI
Trading of Securities
Transfer of Securities
Your Rights
Budget 2009-2010
Budget 2009-2010 Home
Industry Expectations - Budget 2009-2010
Industry Reactions - Budget 2009-2010
Interim Budget 2009-2010 Home
Industry Expectations - Interim Budget 2009
Budget 2008-2009
Railway Budget 2008-2009
Industry Expectations - Budget 2008
Union Budget 2008-2009
Highlights of Budget 2008-2009
Summary of Budget 2008-2009
Industry Reactions - Budget 2008
IPOs
Current IPOs
Past IPOs
IPO Subscription
Mutual Funds
Gold Exchange Traded Fund
MF Unique Holding
Forthcoming Dividends
ELSS Schemes Comparison
Tax Plans
New Fund Offers
Research
Arbitrages
Equity
Market Whispers
Tax Planning
Home
Equity Linked Savings Scheme
Post Office MIS
9% GOI Senior Citizens Savings Scheme
8% Savings (Taxable) Bonds
Kisan Vikas Patra
National Savings Certificate
Public Provident Fund
Stock Report

| More

Lupin Receives Tentative FDA Approvals for Generic Nuvigil Tablets and Generic Oracea Capsules

Posted On: 2013-08-13 03:17:43

MSD, one of the world's leading players in 23-valent Pneumococcal Polysaccharide Vaccines category and Lupin Limited have formed an India-specific strategic partnership. Within the scope of partnership, Lupin will have a non-exclusive license to market, promote and distribute 23-valent Pneumococcal Polysaccharide Vaccine under a different brand name in India.

Pneumococcal disease is an infection caused by bacteria named Streptococcus pneumoniae and it results in variety of invasive and non-invasive pneumococcal diseases with pneumonia being the most common presentation in adults. Pneumococcal disease kills more patients worldwide than any other vaccine preventable diseases. Worldwide 1.6 million people die of pneumococcal disease every year which translates to 3 people dying every minute. Adults with co morbid conditions like chronic lung disease (COPD etc.), diabetes, chronic heart diseases, chronic liver diseases, immune compromised diseases as well as adults more than 65 years of age are at increased risk for pneumococcal diseases than healthy adults.

A recent study from India showed that the case fatality rate due to invasive pneumococcal disease observed in elderly is 26.4% which is much higher than that in children and highlights the need for preventive interventions in adults1

Identifying this significant risk, this partnership is built on a patient centric model, which will help improve vaccination rate for pneumococcal disease, in particular to high risk population group to help reduce incidence and mortality in adults.

Pneumococcal polysaccharide vaccine (PPV)

- Pneumococcal polysaccharide vaccine (PPV) addresses the need of prevention of pneumococcal disease in India with its proven efficacy and broader coverage.

- PPV23 provides broader coverage and has proven efficacy for prevention of pneumococcal diseases which help addresses the need of prevention of pneumococcal disease in India

- Based on the clinical experience since last 3 decades, PPV23 has good safety profile

- Recent India focused study showed that more than 80% of invasive serotype groups of Streptococcus pneumoniae causing disease in the elderly in India are included in the formulation of PPV 23 which makes this vaccine relevant from India perspective

- PPV23 is recommended worldwide for prevention of pneumococcal diseases in adults by leading medical societies like Advisory committee on Immunization Practices, American Diabetes Association, American Thoracic society, Geriatric society of India etc.

Shares of Lupin Ltd was last trading in BSE at Rs.839.60, up by Rs.20.40 or 2.49%. The stock hit an intraday high of Rs.847.55 and low of Rs.817.60.

The total traded quantity was 0.73 lakhs compared to 2 week average of 1.45 lakhs.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

Infosys Expands Footprint in Eastern Europe - Opens Delivery Center in Croatia
Beardsell Ltd fixes May 5, 2017 as record date
Karnataka Bank appoints Prasanna Patil as Company Secretary
Inox Leisure Ltd calls for Board Meeting on May 2, 2017
Wendt India Ltd posts net profit of Rs. 12.05 crores in FY16-17
Hero Motocorp Ltd calls for Board Meeting on May 10, 2017
Panache Innovations Ltd calls for Board Meeting on 27th April,2017 at 5.00 P.M.
Indo-Global Enterprises Ltd announces resignation of company secretary
Compuage Infocom Ltd calls for Board Meeting on Tuesday, 2nd May 2017 at 8.00 PM
Rallis India Ltd recommends final dividend of Rs. 2.50
Narayani Steels Ltd appoints company secretary
PNC Infratech Limited receives NHAI nod for achievement of financial closure
Neuland Laboratories Ltd calls for Board Meeting on May 12, 2017
IFC nominee resigns from Religare Enterprises Ltd
Wendt India Ltd approves appointment of Ms. Hima Srinivas as Director
Bharti Airtel Ltd calls for Board Meeting on May 9, 2017
RSWM Ltd calls for Board Meeting on May 12, 2017
Biocon Ltd to consider bonus issue on Apr 27, 2017
IndusInd Bank inaugurates its third branch in Jamshedpur - expands presence across Jharkhand
Nicco Uco Alliance Credit Ltd approves appointment of Mr. L N Kaul as an Additional Director and MD
TCI Industries Ltd calls for Board Meeting on May 11, 2017
Wendt India Ltd Board approves final dividend of Rs. 15
Pokarna Ltd calls for Board Meeting on May, 08th, 2017 - Monday
GNFC Ltd calls for Board Meeting on May 29, 2017
Captain Pipes Ltd receives Solar Energy Grading from CARE
AYM Syntex Ltd calls for Board Meeting on May 6, 2017
JM Financial Asset Management Limited approves buy-back of up to 10% of outstanding equity capital
Vascon Engineers Ltd calls for Board Meeting on 27th April, 2017
eClerx Services Ltd calls for Board Meeting on Tuesday, May 30, 2017
Finolex Cables Ltd calls for Board Meeting on 30th May, 2017
Bank of Maharashtra calls for Board Meetingg on May 4, 2017
Strides Shasun Ltd announces completion of US FDA inspection at the API Facility at Cuddalore with Zero 483 observations
Digjam Ltd calls for Board Meeting on May 8, 2017
Next Mediaworks Limited calls for Board Meeting on May 4, 2017
N R Agarwal Industries Ltd calls for Board Meeting on May 19, 2017
G N A Axles Ltd calls for Board Meeting on May 5th, 2017
Kkalpana Industries India Ltd announces demise of Director
Reliance Communications' shareholders approve demerger of wireless division
Cochin Malabar Estates & Industries Ltd calls for Board Meeting on May 3, 2017
TTK Prestige Ltd declares interim dividend of Rs. 15
Heritage Foods celebrates silver jubilee with farmer's empowerment as core value
Orient Cement becomes a member of the Cement Sustainability Initiative
Tata Communications ushers in a new era for VICE Media with global cloud-based media platform
Adinath Exim Resources Ltd calls for Board Meeting on Tuesday, May 02, 2017
VKJ Infradevelopers Ltd approves expansion of business
Hexaware Technologies Ltd Board approves Dividend of Rs. 1
Nutricircle soft launches new products under the brand GONOURISH
JL Morison India Ltd calls for Board Meeting on May 2, 2017
Gujarat Industries Power Company Ltd calls for Board Meeting on May 12, 2017
Makers Laboratories Ltd calls for Board Meeting on Thursday, 11th May, 2017


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2017